FDA recalls Brainlab’s neurosurgery device: 5 key points

The FDA recalled Germany-based Brainlab’s Cranial IGS System and Cranial Navigation Systems, according to JD Supra Business Advisor.

Advertisement

Here are five key points:

 

1. The device’s real-time display has inaccuracies that could cause injury or death.

 

2. The real-time display is intended to represent patient anatomy so surgeons can map out procedures preoperatively. The digital picture does not match patient anatomy, however.

 

3. The FDA’s Class I recall includes the company’s cranial-navigation systems before 3.0 and IGS systems distributed between May 1996 and May 2015.

 

4. This recall impacts 1,021 units in Arkansas, California, Colorado, Maryland, North Carolina, Ohio, Pennsylvania and Texas.

 

5. Brainlab plans to amend the issue with a new safety mechanism.

More articles on devices:
Active Implants initiates 2nd NUsurface meniscus implant trial: 4 things to know
BONESUPPORT’s CERAMENT registry hits 230 cases: 5 notes
Episurf Medical’s μifidelity platform reaches 100 case milestone: 3 points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.